• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Leukemia test kit PNACIamp™
tissuefor RT-PCR

Leukemia test kit - PNACIamp™ - Panagene Inc. - tissue / for RT-PCR
Leukemia test kit - PNACIamp™ - Panagene Inc. - tissue / for RT-PCR
Add to favorites
Compare this product
 

Characteristics

Applications
for leukemia
Sample type
tissue
Analysis mode
for RT-PCR

Description

CML (Chronic myelogenous leukemia) patients who has consistently treated with Imatinib (Gleevec), have acquired point mutations in tyrosine kinase domain of BCR-ABL fusion gene. Especially, T315I mutation is known as a mutation associated with Imatinibresistance and observed with high frequency. It is important to monitor patients treated with Imatinibby BCR-ABLfusion gene mutation test to prevent therapy failure due to drug resistance by mutation. FEATURES High sensitivity and specificity even with small amount of DNA(1% LOD with 10 ng wild/mutant type mixed DNA) Real-Time PCR based ready-to-use kit Short running time (within 3 hours)
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.